Abnormal immunity and gene mutation in patients with severe hepatitis-B
Open Access
- 1 January 2003
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 9 (9) , 2009-2011
- https://doi.org/10.3748/wjg.v9.i9.2009
Abstract
Abnormal immunity and gene mutation in patients with severe hepatitis-BKeywords
This publication has 19 references indexed in Scilit:
- Hepatitis B e antigen-negative chronic hepatitis BHepatology, 2001
- A pivotal role of IL-12 in Th1-dependent mouse liver injuryInternational Immunology, 1996
- Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cellsNature, 1994
- Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.The Journal of Experimental Medicine, 1993
- Mutations in the Precore Region of Hepatitis B Virus DNA in Patients with Fulminant and Severe HepatitisNew England Journal of Medicine, 1991
- Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.Proceedings of the National Academy of Sciences, 1991
- Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?Proceedings of the National Academy of Sciences, 1990
- Immunoelectron Microscopic Observation of Intrahepatic Hbeag in Patients With Chronic Hepatitis BHepatology, 1990
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.The Journal of Experimental Medicine, 1987